NCT05866172 2023-05-19
HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC
Sun Yat-sen University
Phase 3 Unknown
Clinical Trials
11 trialsNCT00412022 2023-03-24
HOBOE
National Cancer Institute, Naples
Phase 3 Unknown
NCT05164952 2021-12-21
Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole
Assiut University
Phase 3 Unknown
NCT04045522 2021-07-20
Study on Bisphosphonates Targeting Triple-negative Breast Cancer
Shengjing Hospital
Unknown
NCT03932071 2019-05-06
Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT02480634 2019-01-16
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Unknown
NCT02622607 2017-07-21
Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer
Tang-Du Hospital
Phase 3 Unknown
NCT00326820 2013-03-13
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Wales Cancer Trials Unit
Phase 3 Unknown
NCT01737216 2012-12-31
Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer
Hebei Tumor Hospital
Phase 2 Unknown
NCT01259193 2011-04-14
Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC
Fudan University
Phase 2 Unknown
NCT00912938 2010-02-17
Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients
Korean Breast Cancer Study Group
Phase 4 Unknown